Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis

Background: Chemotherapy-related cognitive impairment (CRCI), or “chemobrain,” isdefined as a phenomenon of cognitive deficits in cancer patients after chemotherapy and is characterized by deficits in areas of cognition, including memory, attention, speed of processing, and executive function, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Durán-Gómez, Noelia, López-Jurado, Casimiro Fermín, Nadal-Delgado, Marta, Pérez-Civantos, Demetrio, Guerrero-Martín, Jorge, Cáceres, Macarena C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100963/
https://www.ncbi.nlm.nih.gov/pubmed/35566489
http://dx.doi.org/10.3390/jcm11092363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100963/
https://www.ncbi.nlm.nih.gov/pubmed/35566489
http://dx.doi.org/10.3390/jcm11092363

Ejemplares similares